362 related articles for article (PubMed ID: 11208439)
1. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.
Czerwionka-Szaflarska M; Chrobot A; Szaflarska-Szczepanik A
Med Sci Monit; 2000; 6(5):964-70. PubMed ID: 11208439
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infection.
Weiland O; Chen M; Lindh G; Mattsson L; Schvarcz R; Sönnerborg A; Wahl M; Wejstål R; Widell A; Norkrans G
Scand J Infect Dis; 1995; 27(5):319-24. PubMed ID: 8588128
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infection.
Weiland O; Chen M; Lindh G; Mattsson L; Schvarcz R; Sönnerborg A; Wahl M; Wejstål R; Widell A; Norkrans G
Scand J Infect Dis; 1995; 27(4):319-24. PubMed ID: 8658063
[TBL] [Abstract][Full Text] [Related]
4. A pilot study of corticosteroid priming for lymphoblastoid interferon alfa in patients with chronic hepatitis C.
Chayama K; Tsubota A; Kobayashi M; Hashimoto M; Miyano Y; Koike H; Kobayashi M; Koida I; Arase Y; Saitoh S; Murashima N; Ikeda K; Kumada H
Hepatology; 1996 May; 23(5):953-7. PubMed ID: 8621174
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of interferon alfa therapy in chronic hepatitis C patients depends primarily on hepatitis C virus RNA level.
Yamada G; Takatani M; Kishi F; Takahashi M; Doi T; Tsuji T; Shin S; Tanno M; Urdea MS; Kolberg JA
Hepatology; 1995 Nov; 22(5):1351-4. PubMed ID: 7590646
[TBL] [Abstract][Full Text] [Related]
6. Treatment of chronic hepatitis C with interferon alpha: long-term follow-up and prognostic relevance of HCV genotypes.
Hopf U; Berg T; König V; Küther S; Heuft HG; Lobeck H
J Hepatol; 1996; 24(2 Suppl):67-73. PubMed ID: 8836892
[TBL] [Abstract][Full Text] [Related]
7. Immunoregulatory cytokines in chronic hepatitis C virus infection: pre- and posttreatment with interferon alfa.
Cacciarelli TV; Martinez OM; Gish RG; Villanueva JC; Krams SM
Hepatology; 1996 Jul; 24(1):6-9. PubMed ID: 8707283
[TBL] [Abstract][Full Text] [Related]
8. Sustained remission and viraemia in chronic hepatitis C treated with recombinant alpha-interferon (rIFN-alpha).
Bresci G; Gambardella L; Parisi G; Banti S; Scatena F; Bertoni M; Capria A
Int J Clin Pharmacol Res; 1995; 15(5-6):175-9. PubMed ID: 8835615
[TBL] [Abstract][Full Text] [Related]
9. Recombinant interferon-alpha and ursodeoxycholic acid versus interferon-alpha alone in the treatment of chronic hepatitis C: a randomized clinical trial with long-term follow-up.
Angelico M; Gandin C; Pescarmona E; Rapicetta M; Del Vecchio C; Bini A; Spada E; Baroni CD; Capocaccia L
Am J Gastroenterol; 1995 Feb; 90(2):263-9. PubMed ID: 7847298
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C plasma viral load is associated with HCV genotype but not with HIV coinfection.
Berger A; von Depka Prondzinski M; Doerr HW; Rabenau H; Weber B
J Med Virol; 1996 Apr; 48(4):339-43. PubMed ID: 8699166
[TBL] [Abstract][Full Text] [Related]
11. Predictive factors for efficacy of interferon therapy in chronic hepatitis type C.
Ishibashi K; Kashiwagi T; Ito A; Tanaka Y; Nagata T; Tamaki J; Azuma M; Kishida Y; Yoshida A; Hikiji AY
Hepatogastroenterology; 1995; 42(5):535-41. PubMed ID: 8751211
[TBL] [Abstract][Full Text] [Related]
12. Intrahepatic hepatitis C RNA levels do not correlate with degree of liver injury in patients with chronic hepatitis C.
McGuinness PH; Bishop GA; Painter DM; Chan R; McCaughan GW
Hepatology; 1996 Apr; 23(4):676-87. PubMed ID: 8666317
[TBL] [Abstract][Full Text] [Related]
13. [Predictive value of a rapid negativity of serum virus C viremia during treatment with interferon alpha in patients with chronic hepatitis C].
Moulin V; Harzic M; Doll J; Dubeaux B; Ghnassia JC; Andrieu J
Pathol Biol (Paris); 1996 May; 44(5):468-72. PubMed ID: 8758497
[TBL] [Abstract][Full Text] [Related]
14. alpha-Interferon retreatment of patients with chronic hepatitis C.
Rabinovitz M; Block G; Finkelstein SD
Am J Gastroenterol; 1996 Aug; 91(8):1523-6. PubMed ID: 8759654
[TBL] [Abstract][Full Text] [Related]
15. Procollagen-III peptide and chronic viral C hepatitis.
Jeffers LJ; Coelho-Little ME; Cheinquer H; Vargas C; Civantos F; Alvarez L; Reddy KR; Parker T; de Medina M; Li X
Am J Gastroenterol; 1995 Sep; 90(9):1437-40. PubMed ID: 7661165
[TBL] [Abstract][Full Text] [Related]
16. The Oklahoma-Pittsburgh experience with interferon alpha in the treatment of HCV disease.
Van Thiel DH; Friedlander L; Fagiuoli S; Molloy P; Kania RJ; Wright H
J Okla State Med Assoc; 1995 Apr; 88(4):154-61. PubMed ID: 7782963
[TBL] [Abstract][Full Text] [Related]
17. [Clinical significance of antibody to Y19 protein in nonA and nonB chronic liver disease].
Sakashita H
Fukuoka Igaku Zasshi; 1993 Apr; 84(4):159-72. PubMed ID: 7686128
[TBL] [Abstract][Full Text] [Related]
18. Retreatment of chronic hepatitis C with interferon.
Toyoda H; Nakano S; Takeda I; Kumada T; Sugiyama K; Osada T; Kiriyama S; Suga T; Ohki H; Ito O
Am J Gastroenterol; 1994 Sep; 89(9):1453-7. PubMed ID: 7521572
[TBL] [Abstract][Full Text] [Related]
19. Hepatic and extrahepatic HCV RNA strands in chronic hepatitis C: different patterns of response to interferon treatment.
Gil B; Qian C; Riezu-Boj JI; Civeira MP; Prieto J
Hepatology; 1993 Nov; 18(5):1050-4. PubMed ID: 8225209
[TBL] [Abstract][Full Text] [Related]
20. Host and viral characteristics affecting the response to interferon therapy in chronic hepatitis C.
Laurent-Puig P; Dussaix E; Altman C; Laval C; Stuyver L; Wilber JC; Babany G; Chopineau S; Bedossa P; Brocheriou I
Eur J Gastroenterol Hepatol; 1995 Apr; 7(4):335-40. PubMed ID: 7541297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]